<DOC>
	<DOCNO>NCT01551394</DOCNO>
	<brief_summary>This phase III multicentric international randomize trial design compare efficacy Meropenem standard care infants 90 day age clinical confirm late-onset sepsis ( LOS ) . The aim ass efficacy , pharmacokinetics safety Meropenem well known documented population .</brief_summary>
	<brief_title>Efficacy , Pharmacokinetics Safety Meropenem Infants Below 90 Days With Clinical Confirmed Late-onset Sepsis</brief_title>
	<detailed_description>The principal objective compare efficacy test cure ( TOC ) visit meropenem standard care ( SOC ) treatment clinical confirm LOS infant ≤ 90 day postnatal age . The secondary objective : - To compare safety profile meropenem SOC - To compare efficacy TOC visit meropenem SOC confirm sepsis - To compare response meropenem SOC day 3 antibacterial therapy - To compare efficacy TOC visit meropenem SOC ignore change antibiotic ( ) safety reason - To compare efficacy TOC visit meropenem SOC SOC regimen - To compare survival follow ( FU ) visit ( 28 day visit ) meropenem arm SOC arm - To compare new infection relapse occur TOC FU visit participant favourable outcome TOC visit treatment arm - To define organisms cause LOS - To study antibacterial susceptibility LOS-causing organism describe clinical microbiological response accord - To compare gut colonization antibiotic resistant organism treatment meropenem SOC - To compare bacterial eradication treatment arm - To compare time NICU discharge across 2 arm - To describe PK meropenem infant ≤ 90 day postnatal age LOS - To evaluate genetic parameter may affect response therapy</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Thienamycins</mesh_term>
	<mesh_term>Gentamicins</mesh_term>
	<mesh_term>Cefotaxime</mesh_term>
	<mesh_term>Cefoxitin</mesh_term>
	<mesh_term>Ampicillin</mesh_term>
	<criteria>Informed consent form sign parents/carers Chronological age 90 day inclusive Chronological age great equal 72 hour life begin LOS Clinical confirm sepsis For infant 44 week inclusive correct age clinical sepsis define , accord Expert Meeting Neonatal Paediatric Sepsis ( Report Expert Meeting Neonatal Paediatric Sepsis 8 June 2010 , EMA London ) , presence last 24 hour least two clinical criterion : hyper hypothermia temperature instability , reduce urinary output hypotension mottle skin impaired peripheral perfusion apnea increase oxygen requirement increase requirement ventilatory support , bradycardia spell tachycardia rhythm instability , feed intolerance abdominal distension , lethargy hypotonia irritability , skin subcutaneous lesion petechial rash sclerema , two laboratory criterion : white blood cell ( WBC ) count &lt; 4 &gt; 20 x 109 cells/L , immature total neutrophil ratio ( I/T ) &gt; 0.2 , platelet count &lt; 100 x 109/L , Creactive protein ( CRP ) &gt; 15 mg/L procalcitonin ≥ 2 ng/mL , glucose intolerance receive normal glucose amount ( 815 g/kg/day ) express blood glucose value &gt; 180 mg/dL hypoglycemia ( &lt; 40 mg/dL ) confirm least two time , acidosis characterize base excess ( BE ) &lt; 10 mmol/L lactate value 2 mmol/L . confirm sepsis define positive culture pathogens sample normally sterile site least one laboratory sign clinical sign ( list ) For child 44 week correct age clinical sepsis define accord Goldstein criterion ( Goldstein et al , 2005 ) least two follow criterion , one must abnormal temperature WBC count : Core temperature &gt; 38.5 °C &lt; 36 °C ; Tachycardia , define mean heart rate &gt; 95th percentile age group absence external stimulus , chronic drug , painful stimulus unexplained persistent elevation 0.5 4 hour time period ; bradycardia , define mean heart rate &lt; 5th percentile age group absence external vagal stimulus , beta blocker drug , congenital heart disease unexplained persistent depression 0.5 hour time period ; Mean respiratory rate &gt; 95th percentile age group mechanical ventilation acute process relate underlying neuromuscular disease receipt general anaesthesia ; Leukocyte count &lt; 5th percentile &gt; 95th percentile age group ( secondary chemotherapyinduced leucopoenia ) . confirm sepsis : positive culture pathogens sample normally sterile site least one laboratory sign clinical sign ( list ) Administration systemic antibiotic 24 hour prior randomisation , unless change drive lack efficacy former regimen ; Severe congenital malformation infant expect survive 3 month ; Other situation treat physician considers different antibiotic regimen necessary ; Known intolerance contraindication study medication ; Participation clinical study investigational drug ; Renal failure ( define AkcanArikan et al. , 2007 ) requirement haemofiltration peritoneal dialysis ; Confirmed sepsis microorganism know resistant study therapy .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>90 Days</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>sepsis</keyword>
	<keyword>neonate</keyword>
	<keyword>meropenem</keyword>
</DOC>